Ipilimumab regulatory update

FDA's Oncologic Drugs Advisory Committee will meet on Feb. 9 to discuss a BLA from Bristol-Myers for ipilimumab to treat metastatic melanoma. The committee had been scheduled to discuss the applicatio...